The Lancet publishes Ravgen research on prenatal testing

Fujirebio's test for monitoring mesothelioma FDA-approved

The Lancet publishes Ravgen research on prenatal testing

Electro-Optical in pivotal trial with MelaFind for melanoma

Audioconference conclusions: Underperformance for Med-tech stocks, but M&A to be robust

Colon cancer found earlier post-Medicare changes

Ikonisys wins FDA clearance for bladder cancer test automation

Adlyfe focused on ‘misfolding’ as key to Alzheimer’s test

MDS to buy Molecular Devices in cash deal valued at $615M

MDS to buy Molecular Devices in cash deal valued at $615M